Sufentanil-Dezocine combination in patient-controlled intravenous anal

Introduction

Pancreatic cancer is one of the most aggressive malignancies, with only 20% of patients eligible for surgical resection at the time of diagnosis.^1–3 These patients often face prolonged hospitalization and significant postoperative…